Francesco Pietro Crispino
Director/Board Member bei APOLLO TYRES LIMITED
Aktive Positionen von Francesco Pietro Crispino
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| APOLLO TYRES LIMITED | Director/Board Member | 03.07.2020 | - |
| Independent Dir/Board Member | 03.07.2020 | - |
Karriereverlauf von Francesco Pietro Crispino
Ehemalige bekannte Positionen von Francesco Pietro Crispino
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| STALLERGENES GREER | Director/Board Member | 07.05.2019 | 31.12.2021 |
Greater Pacific Capital LLP
 Greater Pacific Capital LLP Investment ManagersFinance Greater Pacific Capital LLP (Greater Pacific Capital) is a private equity firm founded in 2005 by Ketan J Patel and Methusalah Joseph Sealy. The firm is headquartered in London. | Founder | - | - |
| BCE INC. | Corporate Officer/Principal | - | - |
Ausbildung von Francesco Pietro Crispino
| University of Oxford | Graduate Degree |
| The University of Chicago | Graduate Degree |
| University of Toronto | Undergraduate Degree |
Statistik
International
| Vereinigtes Königreich | 4 |
| Kanada | 3 |
| Indien | 2 |
Operativ
| Director/Board Member | 2 |
| Graduate Degree | 2 |
| Independent Dir/Board Member | 1 |
Sektoral
| Consumer Services | 4 |
| Communications | 2 |
| Consumer Durables | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| BCE INC. | Communications |
| APOLLO TYRES LIMITED | Consumer Durables |
| Private Unternehmen | 2 |
|---|---|
Greater Pacific Capital LLP
Greater Pacific Capital LLP Investment ManagersFinance Greater Pacific Capital LLP (Greater Pacific Capital) is a private equity firm founded in 2005 by Ketan J Patel and Methusalah Joseph Sealy. The firm is headquartered in London. | Finance |
Stallergenes Greer Ltd.
 Stallergenes Greer Ltd. Pharmaceuticals: MajorHealth Technology Stallergenes Greer Ltd. is a healthcare company, which engages in the development and commercialization of allergy immunotherapy products and services. Its products include sublingual products, subcutaneous products, and veterinary products. The company was founded on December 6, 2013 and headquartered in London, the United Kingdom. | Health Technology |
